{
  "trial_id": "NCT01818557",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "blood glucose testing",
      "label": "met",
      "evidence": "daily"
    },
    {
      "criterion": "gestational age between 20 weeks 0 days and 32 weeks 0 days of gestation",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "singleton pregnancies",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "maternal age over 18 years",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "patients able to read and write in English or Spanish",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "diagnosis of gestational diabetes mellitus using criteria supported by the American College of Obstetrics and Gynecology (ACOG)",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "patients identified as not requiring medical therapy (insulin or glyburide) after the first week of initial blood glucose monitoring",
      "label": "met",
      "evidence": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "diagnosis of GDM made by any method or criteria other than the one outlined above",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "women with pre-existing diabetes mellitus",
      "label": "not_met",
      "evidence": "none"
    }
  ],
  "notes": "16-year-old girl recently diagnosed with myasthenia gravis, class IIa. She complains of diplopia and weakness affecting in her upper extremities.",
  "_meta": {
    "topic_id": "72",
    "trial_id": "NCT01818557",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}